Wong W M, Tam T Cc, Wong M Ky, Lui M Ms, Ip M Sm, Lam D Cl
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.
Hong Kong Med J. 2016 Aug;22(4):334-40. doi: 10.12809/hkmj154673. Epub 2016 Jun 3.
Malignant pleural effusion can be recurrent despite active anti-cancer treatment. Significant malignant pleural effusion leads to debilitating dyspnoea and worsening quality of life in patients with advanced cancer. An indwelling pleural catheter offers a novel means to manage recurrent malignant pleural effusion and may remove the need for repeated thoracocentesis. Spontaneous pleurodesis is another unique advantage of indwelling pleural catheter placement but the factors associated with its occurrence are not clearly established. The aims of this study were to explore the safety of an indwelling pleural catheter in the management of symptomatic recurrent malignant pleural effusion, and to identify the factors associated with spontaneous pleurodesis.
This case series with internal comparisons was conducted in the Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, Hong Kong. All patients who underwent insertion of an indwelling pleural catheter from the initiation of such service from January 2010 to December 2014 were included for data analysis. Patients were monitored until December 2014, with the last catheter inserted in July 2014.
Between 2010 and 2014, a total of 23 indwelling pleural catheters were inserted in 22 consecutive patients with malignant pleural effusion, including 15 (65.2%) cases with malignant pleural effusion as a result of metastatic lung cancer. Ten (43.5%) cases achieved minimal output according to defined criteria, in five of whom the pleural catheter was removed without subsequent re-accumulation of effusion (ie spontaneous pleurodesis). Factors associated with minimal output were the absence of trapped lung (P=0.036), shorter time from first appearance of malignant pleural effusion to catheter insertion (P=0.017), and longer time from catheter insertion till patient's death or end of study (P=0.007).
An indwelling pleural catheter provides a safe means to manage symptomatic malignant pleural effusion. Potential clinical factors associated with minimal output were identified along with the occurrence of spontaneous pleurodesis, which is a unique advantage offered by indwelling pleural catheter.
尽管进行了积极的抗癌治疗,恶性胸腔积液仍可能复发。大量恶性胸腔积液会导致晚期癌症患者出现使人衰弱的呼吸困难,并使生活质量恶化。留置胸腔导管为处理复发性恶性胸腔积液提供了一种新方法,且可能无需反复进行胸腔穿刺术。自发性胸膜固定术是留置胸腔导管的另一个独特优势,但其发生相关因素尚不明确。本研究的目的是探讨留置胸腔导管在处理有症状的复发性恶性胸腔积液中的安全性,并确定与自发性胸膜固定术相关的因素。
本病例系列采用自身对照,在香港玛丽医院内科呼吸医学科进行。纳入2010年1月该项服务开始至2014年12月期间所有接受留置胸腔导管插入术的患者进行数据分析。对患者进行监测直至2014年12月,最后一根导管于2014年7月插入。
2010年至2014年期间,连续22例恶性胸腔积液患者共插入23根留置胸腔导管,其中15例(65.2%)因转移性肺癌导致恶性胸腔积液。根据既定标准,10例(43.5%)患者胸腔积液引流量极少,其中5例拔除胸腔导管后积液未再积聚(即自发性胸膜固定术)。与胸腔积液引流量极少相关的因素包括无肺陷闭(P=0.036)、从首次出现恶性胸腔积液到插入导管的时间较短(P=0.017)以及从插入导管到患者死亡或研究结束的时间较长(P=0.007)。
留置胸腔导管为处理有症状的恶性胸腔积液提供了一种安全的方法。确定了与胸腔积液引流量极少相关的潜在临床因素以及自发性胸膜固定术的发生情况,而自发性胸膜固定术是留置胸腔导管的独特优势。